235 related articles for article (PubMed ID: 27326911)
1. Descriptors and their selection methods in QSAR analysis: paradigm for drug design.
Danishuddin ; Khan AU
Drug Discov Today; 2016 Aug; 21(8):1291-302. PubMed ID: 27326911
[TBL] [Abstract][Full Text] [Related]
2. Application of topological descriptors in QSAR and drug design: history and new trends.
Gozalbes R; Doucet JP; Derouin F
Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
[TBL] [Abstract][Full Text] [Related]
3. Similarity boosted quantitative structure-activity relationship--a systematic study of enhancing structural descriptors by molecular similarity.
Girschick T; Almeida PR; Kramer S; Stålring J
J Chem Inf Model; 2013 May; 53(5):1017-25. PubMed ID: 23489025
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary computation and QSAR research.
Aguiar-Pulido V; Gestal M; Cruz-Monteagudo M; Rabuñal JR; Dorado J; Munteanu CR
Curr Comput Aided Drug Des; 2013 Jun; 9(2):206-25. PubMed ID: 23700999
[TBL] [Abstract][Full Text] [Related]
5. A combined Fisher and Laplacian score for feature selection in QSAR based drug design using compounds with known and unknown activities.
Valizade Hasanloei MA; Sheikhpour R; Sarram MA; Sheikhpour E; Sharifi H
J Comput Aided Mol Des; 2018 Feb; 32(2):375-384. PubMed ID: 29280033
[TBL] [Abstract][Full Text] [Related]
6. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
Marrero-Ponce Y
J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
[TBL] [Abstract][Full Text] [Related]
8. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
9. Using kernel alignment to select features of molecular descriptors in a QSAR study.
Wong WW; Burkowski FJ
IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
[TBL] [Abstract][Full Text] [Related]
10. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of binary QSAR analysis by a GA-based variable selection method.
Gao H; Lajiness MS; Van Drie J
J Mol Graph Model; 2002 Jan; 20(4):259-68. PubMed ID: 11858634
[TBL] [Abstract][Full Text] [Related]
12. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
Roy K; Mitra I
Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
[TBL] [Abstract][Full Text] [Related]
13. Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design.
Veselinović AM; Veselinović JB; Živković JV; Nikolić GM
Curr Top Med Chem; 2015; 15(18):1768-79. PubMed ID: 25961525
[TBL] [Abstract][Full Text] [Related]
14. Feature selection in quantitative structure-activity relationships.
Walters WP; Goldman BB
Curr Opin Drug Discov Devel; 2005 May; 8(3):329-33. PubMed ID: 15892248
[TBL] [Abstract][Full Text] [Related]
15. A review on principles, theory and practices of 2D-QSAR.
Roy K; Das RN
Curr Drug Metab; 2014; 15(4):346-79. PubMed ID: 25204823
[TBL] [Abstract][Full Text] [Related]
16. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
[TBL] [Abstract][Full Text] [Related]
17. HATS5m as an Example of GETAWAY Molecular Descriptor in Assessing the Similarity/Diversity of the Structural Features of 4-Thiazolidinone.
Zapadka M; Dekowski P; Kupcewicz B
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743020
[TBL] [Abstract][Full Text] [Related]
18. Statistical molecular design of balanced compound libraries for QSAR modeling.
Linusson A; Elofsson M; Andersson IE; Dahlgren MK
Curr Med Chem; 2010; 17(19):2001-16. PubMed ID: 20423313
[TBL] [Abstract][Full Text] [Related]
19. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
20. Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.
Wang W; Kim MT; Sedykh A; Zhu H
Pharm Res; 2015 Sep; 32(9):3055-65. PubMed ID: 25862462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
